Long-acting injectable
MedinCell and AbbVie Collaborate on Long-Acting Injectable Development with a Potential Value of $1.9 Billion
MedinCell, AbbVie, Long-acting injectable, Development pact, $1.9 billion
Actionable Insights Powered by AI
MedinCell, AbbVie, Long-acting injectable, Development pact, $1.9 billion